Enveda
Biotechnology company tackling drug discovery through a nature-based approach
10%
Kinnevik stake
SEK 428 m
Fair value 31 March 2024
Biotechnology company tackling drug discovery through a nature-based approach
10%
Kinnevik stake
SEK 428 m
Fair value 31 March 2024